Latest news
Systemic Delivery of Biologics via Inhalation: Overcoming Injection Aversion in Modern Therapies
That was the title of the talk by Dr Orest Lastow, CTO at Iconovo, at the meeting New updates in Drug Formulation & Bioavailability organized by Life Science…
Grundaren av Iconovo, Dr Orest Lastow, om att vara sci-fi-författare
Grundaren av Iconovo, Dr Orest Lastow, har blivit intervjuad av Life Science Sweden om sin nya parallella karriär som sci-fi-författare. Orest kombinerar…
Press releases
Apr 15, 2020, 09:40
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 08, 2020, 16:15
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
Apr 07, 2020, 10:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Mar 27, 2020, 15:18
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 20, 2020, 09:15
News
IR
Swedish
Regulatory
Corporate Information
Other Corporate Information
Mar 19, 2020, 14:18
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 13, 2020, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 11, 2020, 18:20
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
Feb 14, 2020, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Feb 10, 2020, 19:39
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Jan 10, 2020, 08:22
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se